Pancreatic cancer

The Lancet

DOI: 10.1016/s0140-6736(20)30974-0 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 17 stored of 2,490

The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact—A Nationwide, Retrospective Cohort Study
2026 Cancers article Medicine Pancreatic and Hepatic Oncology Research Open access

0

citations
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
2025 Nature Communications article Medicine Pancreatic and Hepatic Oncology Research Open access

10

citations
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
2025 The Lancet Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

53

citations
Preoperative arterial and venous CT radiomics for survival prediction after pylorus preserving pancreatoduodenectomy in pancreatic head cancer
2025 Scientific Reports article Medicine Radiomics and Machine Learning in Medical Imaging Open access

3

citations
Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT
2025 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Peptidase Inhibition and Analysis Open access

4

citations
Intravenous Lidocaine for Refractory Pain in Patients With Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Multicenter Prospective Nonrandomized Pilot Study
2024 Clinical and Translational Gastroenterology article Medicine Pain Management and Opioid Use Open access

9

citations
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures
2024 EBioMedicine article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access

34

citations
CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer
2024 Cancer Letters article Materials Science Nanoparticle-Based Drug Delivery Open access

15

citations
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
2023 Annals of Surgery article Medicine Pancreatic and Hepatic Oncology Research Open access

20

citations
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer
2023 International Journal of Molecular Sciences article Materials Science Nanoparticle-Based Drug Delivery Open access

6

citations
Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
2023 Annals of Surgical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

19

citations
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX – The LAPC-2 trial
2023 Radiotherapy and Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

9

citations
Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study
2023 Annals of Surgical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

7

citations
Serum levels of iCAF ‐derived osteoglycin predict favorable outcome in pancreatic cancer
2022 International Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access

17

citations
External validation of three lymph node ratio-based nomograms predicting survival using an international cohort of patients with resected pancreatic head ductal adenocarcinoma
2022 European Journal of Surgical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

2

citations
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
2022 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

738

citations
Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy
2021 Cancers article Medicine Pancreatic and Hepatic Oncology Research Open access

24

citations

17 results

References 1

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
2020 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access cited by 1 patent

1,106

citations

1 result